Journal News

A look into the rice glycoproteome

Ecem Arpaci
By Ecem Arpaci
June 17, 2025

Proteins undergo posttranslational modifications, such as N-glycosylation, during which a sugar chain is added to the amino acid asparagine at specific sites to form a glycoprotein. N-glycosylation aids cell-to-cell communication as well as pathogen interactions in animals, but scientists know little about this modification in plants.

Oryza sativa in a rice field and surrounding natural scenery in Indonesia.
Syariful Msth via Wikimedia Commons
Oryza sativa in a rice field and surrounding natural scenery in Indonesia.

To address this gap, Cong Lei, Xilong Li and Wenjia Li of Yazhouwan National Laboratory and a research team in China developed a metabolic glycan labeling approach, which they used to map N-glycans in rice. In their Molecular & Cellular Proteomics paper, the authors grew Oryza sativa, or rice, with a nutrient mixture containing N-azidoacetylgalactosamine, or GalNAz, an artificial glycan building block they could track over time. GalNAz has a unique chemical group to which the authors attached an affinity tag using click chemistry. This made it possible to study the glycoproteins with liquid chromatography–tandem mass spectrometry.

The team identified hundreds of rice-specific N-linked glycoproteins involved in essential biological processes such as plant growth, starch metabolism and protein processing. In addition, several identified proteins mapped to the endoplasmic reticulum–associated protein degradation, or ERAD, pathways, which maintain a balance between protein folding and degradation. The authors also found the core proteins of this pathway to be N-glycosylated in two human cell lines, suggesting that its regulation is conserved between species.

As changes in N-glycosylation have been linked to disrupted plant development, it is important to shed light on modified proteins and sites. This workflow can be used on other plants to expand our understanding of plant glycoproteomes for agricultural research and biotechnology.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Ecem Arpaci
Ecem Arpaci

Ecem Arpaci is a biochemistry student at Imperial College London and a research intern at Radboud University Medical Center. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

When oncogenes collide in brain development
Journal News

When oncogenes collide in brain development

March 10, 2026

Researchers at University Medical Center Hamburg, found that elevated oncoprotein levels within the Wnt pathway can disrupt the brain cell extracellular matrix, suggesting a new role for LIN28A in brain development.

The data that did not fit
Research Spotlight

The data that did not fit

March 5, 2026

Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.

Building a career in nutrition across continents
Profile

Building a career in nutrition across continents

March 3, 2026

Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.

Avoiding common figure errors in manuscript submissions
How-to

Avoiding common figure errors in manuscript submissions

Feb. 27, 2026

The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Journal News

Ragweed compound thwarts aggressive bladder and breast cancers

Feb. 26, 2026

Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.

Lipid-lowering therapies could help treat IBD
Journal News

Lipid-lowering therapies could help treat IBD

Feb. 25, 2026

Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.